Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Pelvic Inflammatory Disease/Tubo-ovarian Abscess : Article by

Quick Find
Authors & Editors
Introduction
Differentials
Radiograph
CT SCAN
MRI
Ultrasound
Intervention
Test Questions
Multimedia
References

Related Articles
Appendicitis

Ectopic Pregnancy

Endometrioma/Endometriosis

Inflammatory Bowel Disease

Mesenteric Adenitis

Nephrolithiasis/Urolithiasis

Ovarian Torsion




Patient Education
Sexually Transmitted Diseases Center

Pregnancy and Reproduction Center

Women's Health Center

Pelvic Inflammatory Disease Overview

Pelvic Inflammatory Disease Causes

Pelvic Inflammatory Disease Symptoms

Pelvic Inflammatory Disease Treatment

Chlamydia Overview

Gonorrhea Overview

Female Sexual Problems Overview




Author: Shikha Mudgil, MD, Consulting Staff, Department of Radiology, Riddle Memorial Hospital

Shikha Mudgil is a member of the following medical societies: American College of Radiology

Editors: Harris L Cohen, MD, FACR, Vice Chairman/Associate Chairman (Research Activities), Director, Division of Body Imaging, Professor of Radiology, Stony Brook School of Medicine; Visiting Professor of Radiology, Johns Hopkins School of Medicine; Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand; Karen L Reuter, MD, FACR, Professor, Department of Radiology, Lahey Clinic Medical Center; Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute; Eugene C Lin, MD, Consulting Staff, Department of Radiology, Virginia Mason Medical Center

Author and Editor Disclosure

Synonyms and related keywords: sexually transmitted disease, endometritis, salpingitis, tuboovarian abscess, peritonitis, PID, TOA abscess, Chlamydia trachomatis, C trachomatis, Neisseria gonorrhoeae, N gonorrhoeae

Background

Pelvic inflammatory disease (PID) is one of the most serious complications of sexually transmitted diseases. It is an infection of the female upper genital tract that encompasses a broad category of diseases, including endometritis, salpingitis, salpingo-oophoritis, tubo-ovarian abscess (TOA), and pelvic peritonitis. Prompt diagnosis and treatment of this condition are critical because the complications of PID can be life and fertility threatening.

For excellent patient education resources, visit eMedicine's Sexually Transmitted Diseases Center, Pregnancy and Reproduction Center, and Women's Health Center. Also, see eMedicine's patient education articles Pelvic Inflammatory Disease, Chlamydia, Gonorrhea, and Female Sexual Problems.

Pathophysiology

PID most commonly occurs as a result of Chlamydia trachomatis or Neisseria gonorrhoeae infection of the cervix or vagina that then spreads into the endometrium, fallopian tubes, ovaries, and adjacent structures. Less commonly, direct spread from a nearby infection such as appendicitis or diverticulitis may occur. Hematogenous infection is a rare cause of PID except in cases of tuberculous PID.

Frequency

United States

Annually, there are approximately 1 million women who develop PID.1 An estimated 1 in 8 sexually active adolescent girls develop PID before reaching age 20. Because PID may be asymptomatic and this condition is frequently undiagnosed, the incidence rate is likely higher.1, 2

Mortality/Morbidity

Serious lifelong sequelae may occur if PID is not diagnosed and treated promptly. More than 25% of women with PID have at least 1 complication, which can include ectopic pregnancy, infertility, and/or chronic abdominal pain.

Sex

PID typically affects sexually active women.

Age

The peak incidence rate is in women aged 20-24 years.3 However, if the incidence rate is corrected for sexually active females, it is highest in adolescent girls aged 15-19 years.

Clinical Details

Risk factors

The endocervical canal and the mucus plug are the major barriers to the ascent of the bacteria into the upper genital tract. Changes in the vaginal flora, composition of the mucus plug, and cervical cell type are believed to affect the risk of infection. Endometrial instrumentation also increases the risk of PID.

Diagnosis

The 2006 Centers for Disease Control and Prevention (CDC) criteria for the diagnosis of PID are as follows2:

  •  Minimum criteria (1 or more): 
    • Lower abdominal tenderness
    • Adnexal tenderness
    • Tenderness with cervical motion
  • Additional criteria: Patients with PID should have 1 or more of the following:
    • Signs of lower genital tract inflammation
    • Oral temperature higher than 101ºF
    • Abnormal cervical and vaginal discharge
    • Greatly increased numbers of white blood cells on saline microscopy of vaginal secretions
    • Elevated erythrocyte sedimentation rate
    • Elevated C-reactive protein level
    • Laboratory documentation of cervical infection with C trachomatis or N gonorrhoeae
  • Elaborate criteria (additional findings include the following):
    • Histopathologic evidence of endometritis at endometrial biopsy
    • Thickened fluid-filled tubes with or without free pelvic fluid or a tubo-ovarian complex on transvaginal sonograms or images from other modalities
    • Laparoscopic abnormalities that are consistent with PID

Treatment

PID is commonly treated as an outpatient disease, with the use of oral antibiotics that cover both aerobic and anaerobic organisms, including C trachomatis and N gonorrhoeae. Treatment is usually started before the endocervical culture results are available (empiric therapy) because negative findings do not exclude a diagnosis of PID in the upper genital tract.2 Empiric treatment is recommended if the minimum criteria above (see Diagnosis) are fulfilled and if no other cause for the patient's symptoms is identified.2

The CDC recommends hospitalization and administration of intravenous antibiotics in patients with the following: uncertain diagnosis, pregnancy, failure to adhere to or respond to oral treatment, severe illness, TOA, immunodeficiency, or human immunodeficiency virus infection.2

Preferred Examination

Ultrasonography should be the first diagnostic imaging examination to be performed in cases of suspected PID in which there are nondiagnostic clinical findings. This modality is readily available and noninvasive and can be performed at the patient's bedside.

Transvaginal sonography (TVS) allows detailed visualization of the uterus and adnexa, including the ovaries. The fallopian tubes are usually imaged only when they are abnormal and distended on physical examination, primarily from postinflammatory obstruction. Transabdominal sonography (TAS) is complementary to the endovaginal examination because it provides a more global view of the pelvic contents. Whether TAS (bladder filling required) or TVS (bladder filling not required) is performed first and whether the complementary examination is needed for a final diagnosis is a matter of individual clinical imaging practice.

Magnetic resonance imaging (MRI) serves as an excellent imaging modality in cases in which the ultrasonographic findings are equivocal. In a study by Tukeva et al, the authors compared findings from MRI with sonograms and found that MRI was more accurate than ultrasonography in the diagnosis of PID.4 However, the study was limited to a select group of patients.

Occasionally, computed tomography (CT) scanning may be used as the initial diagnostic study for the investigation of nonspecific pelvic pain in a female, and PID may be found incidentally. Most often, ultrasonography is preferred over CT scanning as the triaging tool in a female child or adolescent with right lower quadrant or pelvic pain, particularly because of concerns about radiation exposure. If the diagnosis of PID is still in question, confirmation with ultrasonography is suggested.

Limitations of Techniques

TVS may be limited by the patient's inability to tolerate the transvaginal examination (although this is not usual). In such cases, only transabdominal findings may be available. Occasionally, the higher frequency and the lower position of the transvaginal transducer limits penetration of the sound beam, and TVS imaging of an unusually high adnexa may not be possible. Sometimes, a patient's large body habitus or abdominal wall scarring limits penetration of the sound beam, adversely affecting TAS.



Appendicitis
Ectopic Pregnancy
Endometrioma/Endometriosis
Inflammatory Bowel Disease
Mesenteric Adenitis
Nephrolithiasis/Urolithiasis
Ovarian Torsion

Other Problems to Be Considered

Chronic Pelvic Pain
Hematoma
Hemorrhagic cyst or corpus luteum
Mittelschmerz
Necrotic pelvic neoplasm



Findings

Radiographic findings are noncontributory.



Findings

CT scan findings are nonspecific in cases of PID in which there is no evidence of an abscess. Inflammation obliterates the pelvic fat planes, with thickening of the fascial planes. If hydrosalpinx is present, a fluid-filled tubular structure may be seen in the adnexa. Typically, a TOA is depicted as a mass; the mass may have regular margins and contain debris similar to that seen in endometriomas or hemorrhagic cysts. Sometimes the margins may be thick and irregular. There may also be an associated low-attenuation area that may represent an adjacent or contained fluid-filled fallopian tube.

Degree of Confidence

Tubular fluid-filled nonvascular structures in the pelvis that are associated with an adnexal mass are suggestive of dilated fallopian tubes that correlate with cases of PID. A finding of an adjacent or surrounding complex mass confirms the diagnosis of TOA.

False Positives/Negatives

Other conditions that can mimic pelvic abscess/TOA include necrotic pelvic neoplasm, hematoma, hemorrhagic physiologic cyst, and endometrioma.



Findings

Hydrosalpinx is depicted as a tubular structure with low signal intensity on T1-weighted MRIs and high signal intensity on T2-weighted images. If the walls are thickened, pyosalpinx should be considered in the differential diagnosis.

Oophoritis may be evidenced by enlarged, polycystic-appearing ovaries with ill-defined margins and adjacent fluid.

TOAs often appear as thick-walled masses with low signal intensity on T1-weighted images and high signal intensity on T2-weighted images. Occasionally, the TOA may be isointense or hyperintense on T1-weighted images, and they may have heterogeneous signal intensity on T2-weighted images.



Findings

Ultrasonography is the most frequently ordered imaging examination when PID is suspected. Most commonly, the ultrasonographic results for PID are normal, because salpingitis alone is not usually associated with imaging findings.

Positive ultrasonography findings of PID may include the following:

  • Uterus: The uterus may be ill defined because of inflammation; however, inflammation of the uterus is an unusual finding.
  • Endometrium: Endometritis may result in central-endometrial-cavity echo thickening and heterogeneity.
  • Fallopian tube: Hydrosalpinx is depicted as a fluid-filled tube. If the tube walls are thickened and if debris is present within the tube, pyosalpinx should be considered in the differential diagnosis. However, a pyosalpinx may occasionally be imaged as an echoless tube, whereas an imaged echo-filled tube may be due to proteinaceous but noninfected fluid in a hydrosalpinx.
  • Ovaries: Oophoritis results in enlarged ovaries with ill-defined margins that often appear adherent to the uterus. Adjacent free fluid may be present in the adnexa or cul-de-sac.
  • TOAs are depicted as complex adnexal masses with thickened walls and central fluid.
  • Hydrosalpinx or pyosalpinx is noted as a tubular, sometimes tortuous echoless or echopenic structure.

Degree of Confidence

Thickening of the endometrium is nonspecific for PID because this finding may also be seen with endometrial hyperplasia, polyps, or cancer. Knowledge of the patient's clinical findings and other signs of infection can help in the differential diagnosis.

Hydrosalpinx and pyosalpinx can usually be readily distinguished from pelvic veins and bowel by visualizing the color flow within the patent blood vessels and peristalsis within the bowel.

Imaging findings in TOAs are usually nonspecific and must be distinguished from endometriomas, ectopic pregnancies, hemorrhagic cysts, ovarian tumors, and abscesses from adjacent organs.



Some significant pelvic abscesses may be drained percutaneously or surgically. Most cases of PID improve with an antibiotic regimen alone.

Special Concerns

Prompt diagnosis and treatment of PID are critical because the complications of this condition can be life and fertility threatening, particularly in adolescent girls and young women of childbearing age.



Click to see larger picture



Media file 1:  Endovaginal sonogram. This image shows anechoic tubular structures in the adnexal area; the finding is compatible with a hydrosalpinx.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Ultrasound

Media file 2:  Transabdominal ultrasound scan. This image shows anechoic tubular structures in the adnexa; the finding is compatible with a hydrosalpinx.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Ultrasound

Media file 3:  Endovaginal ultrasound scan. This image shows anechoic tubular structures in the adnexa; the finding is compatible with a hydrosalpinx.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Ultrasound

Media file 4:  Endovaginal ultrasound scan. This image reveals a tubular structure with debris in the left adnexa; the finding is compatible with a pyosalpinx.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Ultrasound

Media file 5:  Endovaginal ultrasound scan. This image shows a relatively enlarged right ovary in a patient who had pain, increased flow, and a small amount of adjacent free fluid (same patient as in Images 6 and 7). These findings are compatible with oophoritis.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Ultrasound

Media file 6:  Endovaginal ultrasound scan. This image shows a relatively enlarged right ovary, increased flow, and a small amount of adjacent free fluid (same patient as in Images 5 and 7). These findings are compatible with oophoritis.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Ultrasound

Media file 7:  Endovaginal ultrasound scan. This image shows a healthy left ovary (same patient as in Images 5 and 6).
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Ultrasound

Media file 8:  This sonogram demonstrates a markedly heterogeneous and thickened endometrium (same patient as in Image 10). On closer evaluation, a fluid-fluid level in the endometrial cavity is revealed. In the appropriate clinical setting, this finding is compatible with pyometrium, as it was in this case.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Ultrasound

Media file 9:  This sonogram shows a markedly heterogeneous and thickened endometrium, a finding that is compatible with endometritis.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Ultrasound

Media file 10:  This sonogram reveals bilateral complex masses in a patient who had pyometrium (same patient as in Image 8). The finding is compatible with tubo-ovarian abscesses.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Ultrasound

Media file 11:  This sonogram reveals bilateral complex masses in a patient who had pyometrium, a finding that is compatible with tubo-ovarian abscess.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Ultrasound

Media file 12:  Power Doppler sonogram. This image shows increased flow to the wall of a tubo-ovarian abscess (same patient as in Image 11). The inner hypoechoic regions are due to the presence of purulent material.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Ultrasound

Media file 13:  Transabdominal ultrasound scan. This image demonstrates an echogenic region within the endometrium with dirty shadowing, a finding that is compatible with air in the endometrium and endometritis. Additionally, bilateral complex masses are present; this finding is compatible with tubo-ovarian masses.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Ultrasound

Media file 14:  Endovaginal ultrasound scan (same patient as in Image 13). This image was obtained for a better depiction of the clinical details. Endometritis with air in the endometrial cavity and bilateral tubo-ovarian abscesses are shown.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Ultrasound



  1. US National Library of Medicine, National Institutes of Health. Pelvic inflammatory disease (PID). Updated 9/19/2006. MedlinePlus. Available at http://www.nlm.nih.gov/medlineplus/ency/article/000888.htm. Accessed August 10, 2007.
  2. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. Aug 4 2006;55(RR-11):1-94. [Medline][Full Text].
  3. Weström L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol. Dec 1 1980;138(7 pt 2):880-92. [Medline].
  4. Tukeva TA, Aronen HJ, Karjalainen PT, et al. MR imaging in pelvic inflammatory disease: comparison with laparoscopy and US. Radiology. Jan 1999;210(1):209-16. [Medline][Full Text].
  5. Crossman SH. The challenge of pelvic inflammatory disease. Am Fam Physician. Mar 1 2006;73(5):859-64. [Medline][Full Text].
  6. Del Frate C, Girometti R, Pittino M, et al. Deep retroperitoneal pelvic endometriosis: MR imaging appearance with laparoscopic correlation. Radiographics. Nov-Dec 2006;26(6):1705-18. [Medline].
  7. Eschenbach DA, Buchanan TM, Pollock HM, et al. Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med. Jul 24 1975;293(4):166-71. [Medline].
  8. Goharkhay N, Verma U, Maggiorotto F. Comparison of CT- or ultrasound-guided drainage with concomitant intravenous antibiotics vs. intravenous antibiotics alone in the management of tubo-ovarian abscesses. Ultrasound Obstet Gynecol. Jan 2007;29(1):65-9. [Medline].
  9. Golden N, Cohen H, Gennari G, Neuhoff S. The use of pelvic ultrasonography in the evaluation of adolescents with pelvic inflammatory disease. Am J Dis Child. Nov 1987;141(11):1235-8. [Medline].
  10. Golden N, Neuhoff S, Cohen H. Pelvic inflammatory disease in adolescents. J Pediatr. Jan 1989;114(1):138-43. [Medline].
  11. Haggerty CL, Ness RB. Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials. Clin Infect Dis. Apr 1 2007;44(7):953-60. [Medline].
  12. Lawson MA, Blythe MJ. Pelvic inflammatory disease in adolescents. Pediatr Clin North Am. Aug 1999;46(4):767-82. [Medline].
  13. McCormack WM. Pelvic inflammatory disease. N Engl J Med. Jan 13 1994;330(2):115-9. [Medline].
  14. Moeller K, Cohen HL. Sapingo-oophoritis: pelvic inflammatory disease. In: Cohen HL, Sivit C, eds. Fetal & Pediatric Ultrasound: A Casebook Approach. New York, NY: McGraw Hill Professional; 2001:521-5.
  15. Mollen CJ, Pletcher JR, Bellah RD, Lavelle JM. Prevalence of tubo-ovarian abscess in adolescents diagnosed with pelvic inflammatory disease in a pediatric emergency department. Pediatr Emerg Care. Sep 2006;22(9):621-5. [Medline].
  16. Morishita K, Gushimiyagi M, Hashiguchi M, Stein GH, Tokuda Y. Clinical prediction rule to distinguish pelvic inflammatory disease from acute appendicitis in women of childbearing age. Am J Emerg Med. Feb 2007;25(2):152-7. [Medline].
  17. Paavonen J, Kiviat N, Brunham RC, et al. Prevalence and manifestations of endometritis among women with cervicitis. Am J Obstet Gynecol. Jun 1 1985;152(3):280-6. [Medline].
  18. Quiroz FA. Pelvic inflammatory disease. Appl Radiology. 1999;28(10):1-6. [Full Text].
  19. Rome ES. Pelvic inflammatory disease in the adolescent. Curr Opin Pediatr. Aug 1994;6(4):383-7. [Medline].
  20. Savaris RF, Teixeira LM, Torres TG, et al. Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial. Obstet Gynecol. Jul 2007;110(1):53-60. [Medline].
  21. Simms I, Stephenson JM, Mallinson H, et al. Risk factors associated with pelvic inflammatory disease. Sex Transm Infect. Dec 2006;82(6):452-7. [Medline].
  22. Smith KJ, Ness RB, Wiesenfeld HC, Roberts MS. Cost-effectiveness of alternative outpatient pelvic inflammatory disease treatment strategies. Sex Transm Dis. Jul 13 2007;epub ahead of print. [Medline].
  23. Uslu H, Varoglu E, Kadanali S, et al. 99mTc-HMPAO labelled leucocyte scintigraphy in the diagnosis of pelvic inflammatory disease. Nucl Med Commun. Feb 2006;27(2):179-83. [Medline].
  24. Viberga I, Odlind V, Lazdane G. Characteristics of women at low risk of STI presenting with pelvic inflammatory disease. Eur J Contracept Reprod Health Care. Jun 2006;11(2):60-8. [Medline].
  25. Washington AE, Katz P. Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000. JAMA. Nov 13 1991;266(18):2565-9. [Medline].

Pelvic Inflammatory Disease/Tubo-ovarian Abscess excerpt

Article Last Updated: Aug 13, 2007